Clair S. Gutierrez

Clair S. Gutierrez

Auto-generated profile, based on publicly available information

Clair S. Gutierrez

Massachusetts Institute of Technology

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2023 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
PDF file
YPYana D. Petri
Yana D. Petri
CGClair S. Gutierrez
Clair S. Gutierrez
RRRonald T. Raines
Ronald T. Raines
Tools for on‐demand protein activation enable impactful gain‐of‐function studies in biological settings. Thus far, however, proteins have been chemically caged at primarily Lys, Tyr, and Sec, typically through the genetic encoding of unnatural amino acids. Herein, we report that the preferential reactivity of diazo compounds with protonated acids can be used to expand this toolbox to solvent‐accessible carboxyl groups with an elevated p K a value. As a model protein, we employed lysozyme (Lyz), which has an active‐site Glu35 residue with a p K a value of 6.2. A diazo compound with a bioorthogonal self‐immolative handle esterified Glu35 selectively, inactivating Lyz. The hydrolytic activity of the caged Lyz on bacterial cell walls was restored with two small‐molecule triggers. The decaging was more efficient by small molecules than by esterases. This simple chemical strategy was also applied to a hemeprotein and an aspartyl protease, setting the stage for broad applicability.

3 October 2024 in Biochemistry
Verified
Journal Article
Closed access
YPYana D. Petri
Yana D. Petri
RVRuben Verresen
Ruben Verresen
CGClair S. Gutierrez
Clair S. Gutierrez
VKVolga Kojasoy
Volga Kojasoy
EZErika Zhang
Erika Zhang
RRRonald T. Raines
Ronald T. Raines

20 August 2025 in RNA
Verified
Journal Article
Open access
PDF file
CGClair S. Gutierrez
Clair S. Gutierrez
BSBjarne Silkenath
Bjarne Silkenath
VKVolga Kojasoy
Volga Kojasoy
JPJaroslaw A. Pich
Jaroslaw A. Pich
DLDaniel C. Lim
Daniel C. Lim
RRRonald T. Raines
Ronald T. Raines
In clinical uses, RNA must maintain its integrity in serum that contains ribonucleases (RNases), especially RNase 1, which is a human homolog of RNase A. These omnipresent enzymes catalyze the cleavage of the P–O5′′ bond on the 3′ side of pyrimidine residues. Pseudouridine (Ψ) is the most abundant modified nucleoside in natural RNA. The substitution of uridine (U) with Ψ or N 1‑methylpseudouridine (m1Ψ) reduces the immunogenicity of mRNA and increases ribosomal translation, and these modified nucleosides are key components of RNA-based vaccines. Here, we assessed the ability of RNase A and RNase 1 to catalyze the cleavage of the P–O5′′ bond on the 3′ side of Ψ and m1Ψ. We find that these enzymes catalyze the cleavage of UpA up to 10‑fold more efficiently than the cleavage of ΨpA or m1ΨpA. X-ray crystallography of enzyme-bound nucleoside 2′,3′‑cyclic vanadate complexes and molecular dynamics simulations of enzyme·dinucleotide complexes show that U, Ψ, and m1Ψ bind to RNase A and RNase 1 in a similar manner. Quantum chemistry calculations suggested that the higher reactivity of UpA is intrinsic, arising from an inductive effect that decreases the pK a of the 2′‑hydroxy group of U and enhances its nucleophilicity toward the P–O5′′ bond. Experimentally, we found that UpA does indeed undergo spontaneous hydrolysis faster than does m1ΨpA. Our findings inform the continuing development of RNA-based vaccines and therapeutic agents.

16 June 2026 in Journal of Peptide Science
Verified
Journal Article
Open access
OMOscar J. Molina
Oscar J. Molina
CGClair S. Gutierrez
Clair S. Gutierrez
JYJinyi Yang
Jinyi Yang
EWEvans C. Wralstad
Evans C. Wralstad
RRRonald T. Raines
Ronald T. Raines
Modification of lysine residues is a common strategy in protein engineering, whether to prevent posttranslational modifications, control bioconjugation, or improve crystallization. The standard genetic approach—replacement with arginine by site‐directed mutagenesis—preserves positive charge but alters other physicochemical attributes and cannot address the N‐terminal amino group. Here, we characterize reductive methylation as a chemical alternative. This reaction converts every primary amino group to a dimethylamino group rapidly under mild aqueous conditions. Using human ribonuclease 1 and a cytotoxic variant engineered to evade the endogenous ribonuclease inhibitor as model systems, we assess the effects of complete dimethylation on thermostability, enzymatic catalysis, protein–protein interaction, compatibility with bioconjugation, cellular uptake, and intracellular persistence. Dimethylation preserves thermostability and a protein–protein interaction. Enzymatic catalysis, in contrast, is reduced by 10 2 ‐ to 10 3 ‐fold, consistent with the role of catalytic lysine residues. Dimethylation is fully compatible with bioconjugation chemistry. Dimethylated and unmodified ribonucleases show comparable uptake and persistence in human cells. These findings establish reductive methylation as a practical and conservative strategy for lysine modification in protein and peptide engineering and support its use in applications such as biological proteolysis‐targeting chimeras (bioPROTACs).

18 June 2025 in bioRxiv
Verified
Preprint
Open access
CGClair S. Gutierrez
Clair S. Gutierrez
BSBjarne Silkenath
Bjarne Silkenath
VKVolga Kojasoy
Volga Kojasoy
JPJaroslaw A. Pich
Jaroslaw A. Pich
DLDaniel C. Lim
Daniel C. Lim
RRRonald T. Raines
Ronald T. Raines
In clinical uses, RNA must maintain its integrity in serum that contains ribonucleases (RNases), especially RNase 1, which is a human homolog of RNase A. These omnipresent enzymes catalyze the cleavage of the P–O 5″ bond on the 3′ side of pyrimidine residues. Pseudouridine (Ψ) is the most abundant modified nucleoside in natural RNA. The substitution of uridine (U) with Ψ or N 1 -methylpseudouridine (m 1 Ψ) reduces the immunogenicity of mRNA and increases ribosomal translation, and these modified nucleosides are key components of RNA-based vaccines. Here, we assessed the ability of RNase A and RNase 1 to catalyze the cleavage of the P–O 5″ bond on the 3′ side of Ψ and m 1 Ψ. We find that these enzymes catalyze the cleavage of UpA up to 10-fold more efficiently than the cleavage of ΨpA or m 1 ΨpA. X-ray crystallography of enzyme-bound nucleoside 2′,3′-cyclic vanadate complexes and molecular dynamics simulations of enzyme·dinucleotide complexes show that U, Ψ, and m 1 Ψ bind to RNase A and RNase 1 in a similar manner. Quantum chemistry calculations suggested that the higher reactivity of UpA is intrinsic, arising from an inductive effect that decreases the p K a of the 2′ hydroxy group of U and enhances its nucleophilicity toward the P–O 5″ bond. Experimentally, we found that UpA does indeed undergo spontaneous hydrolysis faster than does m 1 ΨpA. Our findings inform the continuing development of RNA-based vaccines and therapeutic agents.

4 June 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
CGClair S. Gutierrez
Clair S. Gutierrez
AKAlia A. Kassim
Alia A. Kassim
BGBenjamin D. Gutierrez
Benjamin D. Gutierrez
RRRonald T. Raines
Ronald T. Raines
Post-translational modifications (PTMs) increase the diversity of the proteome and are vital to organismal life and therapeutic strategies. Deep learning has been used to predict PTM locations. Still, limitations in datasets and their analyses compromise success. Here we evaluate the use of known PTM sites in prediction via sequence-based deep learning algorithms. Specifically, PTM locations were encoded as a separate amino acid before sequences were encoded via word embedding and passed into a convolutional neural network that predicts the probability of a modification at a given site. Without labeling known PTMs, our model is on par with others. With labeling, however, we improved significantly upon extant models. Moreover, knowing PTM locations can increase the predictability of a different PTM. Our findings highlight the importance of PTMs for the installation of additional PTMs. We anticipate that including known PTM locations will enhance the performance of other proteomic machine learning algorithms.